Bio Essence Corporation
BIOE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -41.3% | -11.3% | -30% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67% | 50.3% | 52.8% | 33.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -482.1% | -138.7% | -79.9% | -63.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -404% | -176.2% | -130.3% | -72.9% |
| EPS Diluted | -0.034 | -0.022 | -0.025 | -0.02 |
| % Growth | -54.3% | 9% | -25% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |